Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

LY-315920 examined for pharmacokinetics following continuous infusion in volunteers

Nov. 23, 1999

Food reduces rate (but not exent) of absorption of LU-135252/HMR-4005 in man

Nov. 23, 1999

Soft analogues of amiodarone with rapid, short-lasting antiarrhythmic effects

Nov. 22, 1999

Korean researchers report development of potent angiotensin II antagonists

Nov. 22, 1999

Collateral Therapeutics succeeds in developing a double-barreled gene therapy for CV disease

Nov. 22, 1999

Human pharmacokinetics of OPC-41061 reported at 1999 AAPS

Nov. 19, 1999

Tezosentan is safe and produces beneficial vasodilatory responses in patients with CHF

Nov. 18, 1999

Bosentan safe and effective in CHF during open-label extension of REACH-1

Nov. 18, 1999

Pharmacokinetic profiles of two oral AII antagonists described by Pfizer at AAPS

Nov. 18, 1999

AVI BioPharma files IND with FDA for Resten-NG

Nov. 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...